If you or a loved one have taken the drug Elmiron® and experienced eyesight damage, you should contact our injury firm immediately. Recent studies have demonstrated that this drug used for treating bladder pain is linked to vision loss and eye disease.
Janssen Pharmaceuticals, Inc., owned by multinational corporation Johnson & Johnson, is now facing lawsuits for allowing this harmful drug to continue on the U.S. market without providing warnings to the public of its dangerous side effects.
Important Update 6/30/20: Johnson & Johnson subsidiary Jansen Pharmaceutical Cos. has officially introduced a warning label on Elmiron® regarding the risk of serious eye condition, pigmentary maculopathy.
This is the FIRST time the company has implemented such a warning, which still leaves Janssen liable for injuries that took place before they started warning the public. If you have taken Elmiron® in the past and have suffered eye damage, contact our firm immediately to discuss your legal options.
Fibich, Leebron, Copeland & Briggs is a premier injury law firm based in Houston. We represent clients nationwide who have been harmed by dangerous drugs like Elmiron®. Three of our lawyers are board-certified by the Texas Board of Legal Specialization, which means that we have the resources and expertise necessary to achieve success. We are dedicated to pursuing maximum compensation on our clients’ behalf. Contact us today if you believe you might have been harmed by taking Elmiron®.
We have won several lawsuits against a number of pharmaceutical and medical companies, including against Johnson & Johnson for other dangerous or defective medical products. In total, we’ve recovered over $1 billion dollars in compensation for our clients.
If you have experienced vision loss or been diagnosed with an eye disease while taking Elmiron®, you may be eligible to recover economic damages for your injuries.
Elmiron® is a weak blood thinner. Its active ingredient is pentosan polysulfate sodium (PPS), a compound similar to heparin with anticoagulant (blood-thinning) and fibrinolytic (loosening blood clots) effects.
According to Janssen’s own description of Elmiron®, “It is not known exactly how ELMIRON® works,” but it has been shown to effectively treat bladder inflammation and irritation.
Elmiron® (pentosan polysulfate sodium) is a drug used to treat bladder discomfort associated with any of the following conditions:
Elmiron® hit the market in 1996 and has been prescribed to millions of patients worldwide. It is the only oral medication approved by the FDA for the treatment of Interstitial cystisis.
Janssen’s drug label includes a list of potential side effects, but none of them are related to eyesight.
Our injury firm has had many successes litigating against corporations who failed to warn the public about the dangers associated with their drugs or medical products. We believe that companies should be held accountable for their negligence and failure to warn the public about the dangers associated with their products.
If you were diagnosed with an eye disease and have taken Elmiron®, you should contact Fibich, Leebron, Copeland & Briggs immediately. You may be one of many victims of this drug’s dangerous side effects and could be eligible for compensation.
Important Update 6/30/20: Janssen Pharmaceutical Cos. has introduced a warning label on Elmiron® for the FIRST time. Contact our firm immediately to discuss your legal options if you think you might have been harmed by taking Elmiron.
Suffering from vision loss after taking Elmiron®? Contact our firm today.
Several studies over the last few years have discovered that Elmiron® is likely linked to a type of retina damage and vision loss called “pigmentary maculopathy.” The eye damage is ongoing, progressive, and irreversible. Ophthamologists have long been unaware of the potential dangers of Elmiron®, and therefore have not known to advise patients to stop taking the drug.
The symptoms connected with Elmiron® related to vision loss include:
Important: Damage to the eyes can continue to worsen for years even after you stop taking Elmiron®. According to some studies related to Elmiron’s negative impact on the eyes, it appears that even if a patient stops taking Elmiron®, his or her eye condition can still progressively worsen for years to come.
If it’s been a long time since you’ve taken Elmiron®, but are experiencing vision loss now, you should still contact an injury lawyer. You might be a victim of this drug’s dangerous effects and should get legal help pursuing compensation.
The vision problems linked with Elmiron® are classified as an unusual type of “maculopathy.” Because of how unusual the condition is and because it is so similar to other common eye diseases, some users of Elmiron® were misdiagnosed. If you were diagnosed with an eye disease and have taken Elmiron®, you should contact our injury firm immediately. You may be one of many victims of this drug’s dangerous side effects and could be eligible for compensation.
Patients who took Elmiron® may have been diagnosed or misdiagnosed with the following eye conditions:
From 2015-2018, The Emory Eye Center in Atlanta, GA began seeing a new type of eye disease appear in 6 (six) patients. Using retinal imaging, doctors noticed that this disease was not the same as macular degeneration, although very similar. The fact that all of Emory’s patients who had this strange “retinal maculopathy” were women, they decided to conduct further study. The study found that all 6 women were taking Elmiron® for Interstitial Cystitis (IC).
In April 2019, Emory Eye Center conducted a study of 10 patients who suffered from the bladder condition interstitial cystitis. The patients who had NOT taken Elmiron® had no signs of eye damage.
In 2018, The Interstitial Cystitis Network conducted a survey of IC patients who took Elmiron®. The latest results show that of 1,604 patients who took Elmiron®, 53.87% have developed retinal disease. The IC Network then reported their findings to the FDA and petitioned that a warning label be added to Elmiron®.
Drs. Vora, Patel, and Melles at Kaiser Oakland found the study by Emory Eye Center in the Journal of Ophthalmology and began conducting their own study on a larger scale. The study took place as follows:
Important: Damage to the eyes can continue to worsen for years even after you stop taking Elmiron®. According to some studies related to Elmiron’s negative impact on the eyes, it appears that even if a patient stops taking Elmiron®, his or her eye condition can still progressively worsen for years to come.
If it’s been a long time since you’ve taken Elmiron®, but are experiencing vision loss now, you should still contact an injury lawyer. You might be a victim of this drug’s dangerous effects and should get legal help pursuing compensation.
